In addition, it has been reported that imatinib lowered the CD40 expression in macrophages and GIST cells [199], decreased the binding of CD40 to its ligands CD40L and CD154, which were expressed on activated T-helper cells, and thus led to less CD8+ T cell activation [199]. The gene discussed is CD8A; the disease is gastrointestinal stromal tumor.